ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $168,000 | -41.7% | 41,595 | -42.0% | 0.00% | – |
Q4 2020 | $288,000 | +68.4% | 71,667 | +13.6% | 0.00% | – |
Q3 2020 | $171,000 | +0.6% | 63,066 | -0.3% | 0.00% | – |
Q2 2020 | $170,000 | -6.1% | 63,236 | -20.5% | 0.00% | – |
Q1 2020 | $181,000 | -68.6% | 79,573 | -35.9% | 0.00% | -100.0% |
Q4 2019 | $577,000 | +11.4% | 124,230 | -17.3% | 0.00% | 0.0% |
Q3 2019 | $518,000 | +33.2% | 150,193 | +27.1% | 0.00% | +100.0% |
Q2 2019 | $389,000 | -25.9% | 118,161 | -31.8% | 0.00% | -50.0% |
Q1 2019 | $525,000 | +74.4% | 173,164 | +51.2% | 0.00% | – |
Q4 2018 | $301,000 | +49.8% | 114,539 | +91.3% | 0.00% | – |
Q3 2018 | $201,000 | +673.1% | 59,884 | +409.1% | 0.00% | – |
Q2 2018 | $26,000 | 0.0% | 11,763 | 0.0% | 0.00% | – |
Q1 2018 | $26,000 | -63.9% | 11,763 | -46.9% | 0.00% | – |
Q3 2017 | $72,000 | -51.4% | 22,147 | -51.7% | 0.00% | – |
Q2 2017 | $148,000 | -24.5% | 45,864 | -35.7% | 0.00% | – |
Q1 2017 | $196,000 | +575.9% | 71,378 | +471.0% | 0.00% | – |
Q4 2016 | $29,000 | +7.4% | 12,500 | -17.8% | 0.00% | – |
Q3 2016 | $27,000 | – | 15,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |